PMV Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.35 | -$0.35 | -$0.35 |
| Q2 2024 | 1 | -$0.35 | -$0.35 | -$0.35 |
| Q3 2024 | 4 | -$0.40 | -$0.33 | -$0.36 |
| Q1 2025 | 3 | -$0.42 | -$0.36 | -$0.39 |
| Q2 2025 | 2 | -$0.41 | -$0.41 | -$0.41 |
| Q3 2025 | 2 | -$0.43 | -$0.43 | -$0.43 |
| Q4 2025 | 2 | -$0.44 | -$0.44 | -$0.44 |
| Q1 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2026 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q4 2026 | 1 | -$0.49 | -$0.49 | -$0.49 |
PMV Pharmaceuticals, Inc. Earnings Date And Information
PMV Pharmaceuticals, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.37 earnings per share for the quarter, missing analysts' consensus estimates of $-0.35 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. PMV Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.44 diluted earnings per share) and currently has a price-to-earnings ratio of -1.61. PMV Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
PMV Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.35 | -$0.37 | -0.02 | $0 | $0 |
| 08/08/2024 | Q2 2024 | -$0.34 | -$0.02 | 0.32 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.35 | -$0.30 | 0.05 | $0 | |
| 02/29/2024 | Q4 2023 | -$0.39 | -$0.31 | 0.08 | $1.62 M | |
| 11/09/2023 | Q3 2023 | -$0.45 | -$0.34 | 0.11 | $0 | |
| 08/09/2023 | Q2 2023 | -$0.47 | -$0.38 | 0.09 | $0 | |
| 05/10/2023 | Q1 2023 | -$0.48 | -$0.37 | 0.11 | $0 | |
| 03/01/2023 | Q4 2022 | -$0.44 | -$0.42 | 0.02 | $0 | |
| 11/08/2022 | Q3 2022 | -$0.42 | -$0.40 | 0.02 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.41 | -$0.38 | 0.03 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.42 | -$0.41 | 0.01 | $0 | |
| 03/01/2022 | Q4 2021 | -$0.35 | -$0.41 | -0.06 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.31 | -$0.33 | -0.02 | $0 | |
| 08/13/2021 | Q2 2021 | -$0.29 | -$0.29 | 0 | $0 | |
| 05/14/2021 | Q1 2021 | -$0.26 | -$0.26 | 0 | $0 | |
| 03/03/2021 | Q4 2020 | -$1.27 | -$1.74 | -0.47 | $0 | |
| 11/13/2020 | Q3 2020 | -$0.34 | -$1.46 | -1.12 | $0 | |
| 06/29/2020 | Q2 2020 | -$0.19 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.23 | $0 | |||
| 12/30/2019 | Q4 2019 | -$0.23 | $0 |
PMV Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is PMV Pharmaceuticals, Inc.'s earnings date?
PMV Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to PMV Pharmaceuticals, Inc.'s earnings conference call?
The conference call for PMV Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read PMV Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for PMV Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does PMV Pharmaceuticals, Inc. generate each year?
PMV Pharmaceuticals, Inc. (:PMVP) has a recorded net income of $0. PMV Pharmaceuticals, Inc. has generated $-1.44 earnings per share over the last four quarters.
-
What is PMV Pharmaceuticals, Inc.'s price-to-earnings ratio?
PMV Pharmaceuticals, Inc. (:PMVP) has a price-to-earnings ratio of -1.61 and price/earnings-to-growth ratio is 0.52.
